Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  PerkinElmer, Inc.    PKI

PERKINELMER, INC.

(PKI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
159.25(c) 151.98(c) 151.52(c) 148.13(c) 148.52(c) Last
1 316 447 1 389 433 1 111 192 859 481 824 867 Volume
-0.32% -4.57% -0.30% -2.24% +0.26% Change
More quotes
Financials (USD)
Sales 2020 3 602 M - -
Net income 2020 619 M - -
Net Debt 2020 1 463 M - -
P/E ratio 2020 26,9x
Yield 2020 0,19%
Sales 2021 4 121 M - -
Net income 2021 753 M - -
Net Debt 2021 549 M - -
P/E ratio 2021 22,1x
Yield 2021 0,19%
Capitalization 16 630 M 16 630 M -
EV / Sales 2020 5,02x
EV / Sales 2021 4,17x
Nbr of Employees 13 000
Free-Float 99,2%
More Financials
Company
PerkinElmer, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (before intra-group eliminations) break down by family of products as follows : - analytical tools and instruments (60.6%): biological molecular research tools, thermal analysis software, chemical and... 
More about the company
Notations Surperformance© of PerkinElmer, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about PERKINELMER, INC.
01/14PERKINELMER : Obtains FDA Emergency Use Approval for COVID-19 RT-PCR Assay for A..
MT
01/14PERKINELMER : SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing
BU
01/11PERKINELMER INC : Other Events (form 8-K)
AQ
01/11PERKINELMER : Raises Fiscal Q4 Adjusted Earnings Guidance
MT
01/11PERKINELMER : Earnings Flash (PKI) PERKINELMER Expects Q4 EPS $3.60
MT
01/11PERKINELMER INC : Results of Operations and Financial Condition (form 8-K)
AQ
01/11PERKINELMER : Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, ..
BU
01/07PERKINELMER INC : Other Events (form 8-K)
AQ
01/07SECTOR UPDATE : Health Care Stocks Add to Early Rise, Supported by Biotech Compa..
MT
01/07SECTOR UPDATE : Modest Advance for Health Care Stocks Despite Larger Gains for B..
MT
01/07PERKINELMER : Wells Fargo Upgrades PerkinElmer to Overweight from Equalweight, A..
MT
01/07Wall Street Sees Upbeat Open as US Congress Certifies Biden's Win After Capit..
MT
01/07PERKINELMER : to Acquire Oxford Immunotec for $591 Million
MT
01/07PERKINELMER : to Acquire Oxford Immunotec Global PLC
BU
2020PERKINELMER : Charnwood Lighthouse Lab Goes Live Processing Thousands of COVID-1..
PU
More news
News in other languages on PERKINELMER, INC.
2020PERKINELMER : obtient le marquage CE pour un panel respiratoire multi-analyses i..
2020PERKINELMER : erhält CE-Kennzeichnung für auf Atemwegsinfektionen, einschließlic..
2020PERKINELMER : publication des résultats annuels
2020PERKINELMER : Veröffentlichung des Jahresergebnisses
2019Tecan trouve un nouveau responsable pour l'unité Partnering Business
More news
Analyst Recommendations on PERKINELMER, INC.
More recommendations
Stock Trading Strategies
PERKINELMER, INC. - 01/06
The revival in interest should continue
BUY
More Stock Trading Analysis
Chart PERKINELMER, INC.
Duration : Period :
PerkinElmer, Inc. Technical Analysis Chart | PKI | US7140461093 | MarketScreener
Technical analysis trends PERKINELMER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 152,33 $
Last Close Price 148,52 $
Spread / Highest target 29,9%
Spread / Average Target 2,57%
Spread / Lowest Target -33,3%
EPS Revisions
Managers and Directors
NameTitle
Prahlad Ramadhar Singh President, CEO, COO & Director
Alexis Platon Michas Non-Executive Chairman
James M. Mock Chief Financial Officer & Senior Vice President
Peter Barrett Independent Director
Sylvie Louise Grégoire Independent Director
Sector and Competitors